PREVALENCE OF CHRONIC KIDNEY DISEASE AND ASPIRIN USE AMONG TYPE 2 DIABETES PATIENTS IN KRANAUN DISTRICT, KHON KAEN

Abstract

Kidney disease is quite a common condition that has been observed among Type 2 Diabetes patients. The actual causes of kidney problems can be triggered by various risk factors. This descriptive cross-sectional study was conducted in order to study prevalence of chronic kidney disease and aspirin use among Type 2 Diabetes patients. For this study, 975 medical history records were examined. These medical profiles belonged to Type 2 Diabetes patients, who had sought health services from Kanuan Crown Prince Hospital from October 1^st, 2017 to September 30^th 2018. The prevalence was represented by using 95% confidence intervals. Particularly in the research, it was observed that 68.4% of samples were female, 64.1% were more than 60 years old, 57.7% were graduated from high school, 87.2% were farmers, 86% had health insurance as a universal health coverage, 42.1% had BMI in obesity, 77% had additional health restrictions, 20% were smoking, 20.3% were drinking alcohol, 35% had been had diabetes more than 10 years, 70.4% had diabetes complications, 60.7% had LDL level less than 100mg/dL, 78.8% had FBS level greater than 126 mg/dL, 55.8% were greater than 7.5% in range of HbA1C, 28.9% had microalbuminuria, 19.4% had systolic greater than 140 mmHg  and chronic kidney disease had been found in 24.9 % (95% CI = 22.2 – 27.8) of Type 2 Diabetes patients, while 62.8 % of the samples (95% CI = 59.7 – 65.8) had reported to have frequently taken aspirin. Conclusion and suggestion, the prevalence of chronic kidney disease among type 2 diabetes patients is quite high, especially in microalbuminuria patients. Therefore, in order to reduce or retard chronic kidney pathogenesis among type 2 diabetes patients, both primary and secondary level of involved public health service units should provide knowledge of factors related to chronic kidney disease in diabetes patients and closely monitor the incidence rate of chronic kidney disease in microalbuminuria patients. Moreover, the prevalence of aspirin takes among type 2 diabetes patients is high, especially in the patients who are more than 60 years old. Thus, effectiveness evaluation of using aspirin for complications prevention among type 2 diabetes patients should be provided.